OpenVSafe by OpenVAERS
Search V-safe

9C3-51936-68241

3 vaccinations 6 coded responses 11 check-ins 6 free-text entries 5 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
201 / VA
Registered
2021-05-16
Relationship
Self
Race
Other
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
1424447 (opens in a new window) high 10 / 11 — 4 of 14 VAERS symptoms same dose (2) VA matches 2021-05-11 / 2021-05-12 / 2021-06-24
received 38 days after the last call
case 697999

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-04-14
    Dose 1 — Pfizer-BioNTech
  2. 2021-05-11
    Dose 2 — Pfizer-BioNTech
  3. 2021-05-16
    Registered in v-safe
  4. 2021-05-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Vaginal haemorrhage — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Vaginal bleeding and clotting since the first dose.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-05-16
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  6. 2021-05-17
    Survey response — days 1–6 daily, dose 2
    MedDRA: Unevaluable event — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Missing appointments.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-05-17
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  8. 2021-05-18
    Survey response — day 7, dose 2
    MedDRA: Office visit — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: I have an appointment scheduled for bloodwork. Rheumatology and PCP
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-05-18
    Report sent to call center — day 7, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  10. 2021-05-25
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-06-01
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  12. 2021-06-10
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-06-18
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-06-22
    Survey response — day 42, dose 2
    MedDRA: Cough, Fatigue, Headache — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Cough, headache, fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-06-22
    Report sent to call center — day 42, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  16. 2021-06-24
  17. 2021-06-24
    Call successful
    Completed over the phone
  18. 2021-08-11
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  19. 2021-11-09
    Survey response — 6 months, dose 2
    MedDRA: Asthenia, Brain fog, Chills, Fatigue, Heart rate increased, Muscle spasms, Myalgia, Rash, Swelling — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Swelling, on and off body and face rash, increased tiredness, weakness, chills, muscle pain/spasms, faster heartbeat, and brain fog
    MedDRA releases: 2024-11 · check-in free text available
  20. 2021-11-09
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  21. 2021-11-10
    Call successful
    Reported to VAERS during previous contact from GDIT
  22. 2021-11-19
    Dose 3 — Pfizer-BioNTech
  23. 2022-05-22
    Survey response — 6 months, dose 3
    MedDRA: Brain fog, Fatigue, Insomnia, Malaise, Myalgia, Palpitations — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Increased Fatigue, brain fog, muscle pain, heart palpitations on and off, insomnia, and being exhausted. Not feeling well.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-04-14Pfizer-BioNTech
22021-05-11Pfizer-BioNTech
32021-11-19Pfizer-BioNTech No

Call center

5 call center cases

5 successful

VAERS report filed, before or during a call: 5

See the call center timeline

Free text

Release 8 — days 1–6 daily, dose 2

2021-05-16

Systemic reaction (other): Vaginal bleeding and clotting since the first dose.

2021-05-17

Healthcare visit (other): Missing appointments.

Release 8 — day 7, dose 2

2021-05-18

Healthcare visit (other): I have an appointment scheduled for bloodwork. Rheumatology and PCP

Release 9 — day 42, dose 2

2021-06-22

Symptoms: Cough, headache, fatigue

Release 10 — 6 months, dose 2

2021-11-09

Symptoms: Swelling, on and off body and face rash, increased tiredness, weakness, chills, muscle pain/spasms, faster heartbeat, and brain fog

Release 11 — 6 months, dose 3

2022-05-22

Symptoms: Increased Fatigue, brain fog, muscle pain, heart palpitations on and off, insomnia, and being exhausted. Not feeling well.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
HCVOUnevaluable event ✓ ✓ ✓
SDAsthenia · · ✓
SDBrain fog · · ✓
SDChills · · ✓
SDCough ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDHeart rate increased · · ✓
SDInsomnia · · ✓
SDMalaise · · ✓
SDMuscle spasms · · ✓
SDMyalgia · · ✓
SDPalpitations · · ✓
SDRash · · ✓
SDSwelling · · ✓
SROVaginal haemorrhage ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release